Medications

PowerPlan: Acetylcysteine and Albuterol Plan

New Powerplan – Acetylcysteine and Albuterol Plan

Per policy UMC SPP # 1.6.44 Acetylcysteine (Mucomyst) inhalation must be administered in conjunction with a bronchodilator. To facilitate this, we have built a new powerplan Acetylcysteine and Albuterol Plan. The plan can be ordered utilizing the brand name Mucomyst as well Mucomyst and Albuterol Plan.

The scheduled go-live date for the new plan is December 5, 2018. Upon release of the new plan the acetylcysteine/Mucomyst inhalation orders will only be available within the powerplan. The oral form of acetylcysteine/Mucomyst will remain available for one off orders.

Educational Handout

Contrast Documentation on MAR

  • As of November 26, 2018, radiology contrast documentation will be visible on the MAR for any MRI cases performed at UMC or UMC Southwest Medical
  • Rad techs will document the contrast given in RadNet and it will flow to the MAR as a discontinued order similar to the current SurgiNet Anesthesia workflow
  • Contrast orders will be placed under the ordering provider of the exam and the order will go to that physician’s message center inbox for co-signature.
  • The remaining radiology areas will follow the schedule below for implementation:
    • o   Dx (X-Ray):                 1/7/19 – 1/18/19
    • o   Interventional Rad:    1/21/19 – 2/1/19
    • o   Cat Scan (CT):            2/4/19 – 2/15/19

Medication Modification: Route and Dosage Form Lock

Route and Dosage Form Lock on Modification

Why:

In an effort to decrease potential medication errors and increase scanning compliance rates, Use and Standards approved locking the route and drug form fields when an order is modified.

When: 06-27-2018

After Lock on Modify

Initial order – the route and drug form are able to be changed

 

When ‘Modify’ is selected on a previously entered order the Route and Drug Form are not able to be changed.

Instead of ‘Modify’ right click and select ‘Cancel/Reorder’

Tamiflu Dosing Reminder

Per manufacturer and pharmacy recommendations, Tamiflu should be adjusted for renal impairment.

Flu Season is upon us and with so many providers prescribing Tamiflu, it is important to remember that this drug needs to be renally dosed.

(there has been a large influx of Dose Range Checking Alerts on patients with poor renal function)

See screenshot below:


Drug-Food Alerts: Review and Suppress for Encounter

Coming in January-- Drug-Food Alerts:  Review and Suppress for Encounter.

Functionality: Will allow providers to filter a Drug-Food alert for themselves only for a specific patient for the duration of the patient’s encounter. Providers and IT personnel will have the ability to remove filtering.

How to Suppress the Drug-Food alert:

1)      Select ‘Review & Suppress for Encounter’ as an Override Reason on the alert

2)      Select ‘Continue’

How to remove suppression:

1)      Select ‘Check Interactions’ at the top of the patient’s Order Profile

2)      A red sphere appears to the left of all orders with interactions. Find the medication in question and click to view all interactions for the order. See allergy example below.

3)      Under Provider Filtered Alerts, check the box under ‘Unfilter’

4)      Select Continue.

5)      This will cause the alert to fire again upon order entry of that medication.